Abstract. In the present study, we measured prostanoid synthesis and the expression of genes associated with prostanoid signaling in human non-small cell lung carcinoma (NSCLC) cell lines and in primary human tumors. Consistent with the proposed growth promoting role of PGE 2 , we found that NSCLC cell lines frequently co-expressed the genes encoding cyclooxygenase-2 and the prostaglandin E 2 (PGE 2 ) receptors EP1, 2 and 4 concomitant with the synthesis of PGE 2 . In contrast, NSCLC cells did not synthesize appreciable amounts of prostaglandin I 2 (PGI 2 , prostacyclin), lacked PGI 2 synthase (PGIS) and did not express the gene coding for the PGI 2 receptor IP at detectable levels. In agreement with this finding, PGIS mRNA levels were dramatically diminished in primary human tumor samples as compared to matched normal lung tissue. Finally, thromboxane A 2 (TxA 2 ) was synthesized in NSCLC cell lines, but transcription of the gene coding for the TxA 2 receptor TP was not observed in these cells. In marked contrast, lung fibroblasts synthesized all three prostanoids and their receptors at high levels. While the observed expression patterns were consistent with the existence of autocrine/paracrine PGE 2 signaling loops in NSCLC cells, PGI 2 -and TxA 2 -mediated signals may play a role in tumor stroma cells.
Introduction
The cyclooxygenases (Cox-1, Cox-2) are rate-limiting enzymes in the synthesis of all prostanoids from arachidonic acid (1) . Research in the past decade has clearly established Cox-2 as a crucial player in tumor growth and progression (2) (3) (4) . Cyclooxygenases catalyze a two-step reaction that converts arachidonic acid to prostaglandin H 2 (PGH 2 ), which in turn serves as the precursor for the synthesis of the biologically active prostanoids PGD 2 , PGE 2 , PGF 2 , PGI 2 (prostacyclin) and thromboxane A 2 by specific prostanoid synthases (1) . The prostanoids act as agonists of G-proteincoupled membrane receptors, termed DP, EP1 through EP4, FP, IP and TP, which in turn trigger multiple second messenger generating systems (5, 6) . Several specific components of this prostanoid signaling network have been associated with oncogenesis, in particular PGE 2 and its membrane receptors EP2, EP3 and EP4 (6) . These conclusions are based on results obtained with knock-out mice as well as selective agonists or inhibitors (7) (8) (9) (10) (11) (12) (13) . On the other hand, the role of PGI 2 is controversial, as both tumor growth-promoting and inhibitory effects have been described (14) (15) (16) . The role of other prostanoids is largely unclear, even though TxA 2 has been reported to enhance tumor growth in mice (17) . In human non-small cell lung carcinoma (NSCLC), expression of Cox-2 and prostaglandin E 2 synthase (PGES) has been demonstrated in several studies (18) , and there is strong evidence for a tumor-promoting role of Cox-2 and most likely PGE 2 on these tumors (19) (20) (21) (22) (23) (24) . Thromboxane A 2 synthase (TxAS) and prostaglandin I 2 synthase (PGIS) expression in NSCLCs has been analyzed, but this study relied entirely on immunohistochemistry (25) . We therefore sought to perform a systematic analysis of prostanoid synthesis and gene expression associated with prostanoid signaling in human NSCLCs. RNA isolation. RNA was isolated by using the RNeasy™ kit (Qiagen, Hilden, Germany) following the manufacturer's protocol. Qia shredders (Qiagen) were used to break down genomic DNA of lysed cells.
Materials and methods

Cell
Reverse transcriptase (RT-PCR) and real-time PCR (qPCR).
cDNA was synthesized using 1 μg of RNA, oligo(dT) primers and reverse transcriptase according to the manufacturer's protocol (Roche Diagnostics). RT-PCR was performed with Platinum Taq polymerase (Invitrogen, Karlsruhe, Germany). qPCR reactions were carried out with the Absolute QPCR SYBR-Green mix (Abgene, Hamburg, Germany) at a primer concentration of 0.2 μM in an Mx3000P Real-time PCR system (Stratagene, La Jolla, CA) for 45 cycles. Primers and annealing conditions were as described in Table I . For qPCR experiments, L27 was used as the normalizer. Results were expressed as Ct values corrected for differences in L27 expression (average Ct value for L27=20).
Prostanoid analysis by GC/MS/MS analysis.
For the determination of prostanoid release, 10 6 cells were cultured on 6-cm tissue culture dishes in 5 ml of fresh DMEM + 10% fetal bovine serum for 24 h. Samples were prepared as described (27) with minor modifications. Briefly, cell culture supernatants were spiked with ~10 ng of deuterated internal standards, and the solvent was removed. The methoxime was obtained through reaction with an O-methylhydroxylamine hydrochloride-acetate buffer. After acidification to pH 3.5, prostanoid derivatives were extracted, and the pentafluorobenzylesters were formed. Samples were purified by thinlayer chromatography, and two broad zones with R v 0.03-0.39 and 0.4-0.8 were eluted. After withdrawal of the organic Table I . The primers and annealing conditions. 
layers, trimethylsilyl ethers were prepared by reaction with bis(trimethylsilyl)-trifluoroacetamide and thereafter subjected to GC/MS/MS analysis on a Finnigan (Thermo Electron Corp., Dreieich, Germany) MAT TSQ700 GC/MS/MS equipped with a Varian (Palo Alto, CA) 3400 gas chromatograph and a CTC A200S (27) .
Immunoblot analysis. Expression of PGIS protein was analyzed by immunoblot analysis using a rabbit polyclonal anti-PGIS antibody as previously described (28) . Briefly, 20 μg of total cell lysate was separated on 10% SDS-PAGE, blotted onto nitrocellulose, and probed with the rabbit polyclonal anti-PGIS antibody (diluted 1:500).
Results
Prostanoid synthesis in human NSCLC cells and fibroblasts.
We first measured the synthesis of prostanoids by 10 different human NSCLC cell lines. PGE 2 was consistently found in the growth medium of all 10 cell lines tested, albeit at variable levels, with the highest values found for A549, H2073, H596 and H322 cells (Fig. 1A) . In contrast, the concentration of 6-keto-PGF 1α (a direct metabolite of, and marker for, the unstable PGI 2 ) was very low or undetectable, and in all cases clearly below the biosynthetic rate of normal human bronchial epithelial cells (HBEPCs). In contrast, TxB 2 , a direct metabolite of TxA 2 , was released by all NSCLC cell lines at moderate but significantly higher levels compared to HBEPCs. PGD 2 was also determined but was very low in all cases including HBEPCs (data not shown). To determine whether the lack of PGI 2 synthesis was due to ratelimiting substrate concentrations, we also performed the experiment in the presence of 10 μM arachidonic acid (Fig. 1B) . However, in contrast to PGE 2 , no significant effect on the release of 6-keto-PGF 1α was observed. Likewise, the simultaneous stimulation of Cox-2 by the phorbol ester TPA and a calcium ionophore further enhanced PGE 2 synthesis in the absence of a significant increase in the release of 6-keto-PGF 1α (Fig. 1B) . We also determined prostanoid synthesis in human fibroblasts (HEL; Fig. 1C ). As expected, these cells released high levels of PGE 2 , 6-keto-PGF 1α and TxB 2 .
Expression of genes encoding enzymes of prostanoid synthesis and prostanoid receptors. Next, we investigated the expression of the Cox-1 and Cox-2 genes in NSCLC cells in comparison to WI38 lung fibroblasts ( Fig. 2A) . As expected, Cox-2 was the predominantly expressed subtype observed in all NSCLC cells but H2073 strongly expressed both Cox-1 and Cox-2. The levels of Cox-2 mRNA in NSCLC cell lines showed a good correlation with the rate of PGE 2 biosynthesis (Fig. 1A) . Consistent with the lack of PGI 2 synthesis, many of the NSCLC cell lines did not express PGIS at detectable levels, and in those cases where PGIS mRNA was found, PGIS protein was extremely low or undetectable (Fig. 2B) . This suggests that NSCLC cells down-regulate the synthesis of PGI 2 at multiple levels, including transcriptional and translational mechanism(s). Analysis of the mRNA expression profiles for all known prostanoid membrane receptors showed a high and almost uniform expression for EP1, EP2 and EP4, while expression of EP3, IP and TP was basically undetectable in the vast majority of the NSCLC cell lines (Fig. 2C) . In contrast, EP1, EP2, EP4, IP and TP expression was clearly detectable in human fibroblasts (Fig. 2C) . cell lines derived from mouse lung adenoma and adenocarcinoma (Fig. 3) . All four cell lines showed a high rate of PGE 2 synthesis, failed to release 6-keto-PGF 1α at significant levels and showed low but readily detectable levels of TxB 2 release. These data are in agreement with our observation made with human lung cancer cell lines, suggesting that these findings are of general relevance to lung adenocarcinomas.
Gene expression patterns in primary human NSCLCs.
Finally, we analyzed the expression of PGIS in five matched pairs of human NSCLCs and normal lung tissue to exclude that the lack of PGI 2 synthesis observed in NSCLC cell lines is a cell culture artifact. As can be seen in Fig. 4 , expression of PGIS mRNA was dramatically reduced in all tumor tissue samples compared to the normal lung (5-10 Ct values, corresponding to an ~30-to 1000-fold difference). This result is fully compatible with our study of established lung tumor cell lines, and is also in agreement with published immunohistochemical observations (25) . We also measured IP expression, which was equally low in all tumor and lung tissue samples analyzed (Ct ≥31; data not shown). This finding is also in agreement with our cell culture data.
Discussion
A vast body of evidence suggests that the tumor-promoting effects of Cox-2 are attributable to a major extent to overproduction of PGE 2 and the ensuing stimulation of PGE 2 membrane receptors (7, 8, 10, 11, 9, (29) (30) (31) (32) . Particularly strong evidence derived from mouse models exists for EP2 and EP4 in gastrointestinal tumors (29, 30) and mammary carcinoma (32) . Our findings obtained with human NSCLCs are consistent with this picture and suggest that autocrine/paracrine PGE 2 signaling might be of high relevance for these cells. In contrast, TxA 2 is synthesized by NSCLCs at appreciable amounts, but NSCLC cells fail to express the gene encoding its receptor, TP. On the other hand, fibroblasts strongly express TP and synthesize TxA 2 , which would be compatible with a role in the growth supporting stroma. Strikingly, NSCLC cells do not synthesize PGI 2 due to a lack of PGIS and do not express the PGI 2 receptor gene, IP. These findings indicate that PGI 2 -driven signaling pathways are not essential for NSCLC cells, and may even point to a potentially negative effect on tumor growth. This hypothesis is indeed supported by a previous study that showed suppression of lung adenoma growth by the pneumocyte-directed expression of a PGIS transgene in mice (15) .
